Study of Capecitabine to Treat Recurrent High Grade Gliomas
NCT00717197
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Malignant Glioma
Interventions
DRUG:
Capecitabine
Sponsor
University of Florida